<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Pharma Marketing News via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Pharma Marketing News' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Pharma+Marketing+News&t=Pharma+Marketing+News&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 01:31:34 +0100</lastBuildDate>
        <item>
            <title>Is There a Cure for Mediocre Pharma Mobile Apps?</title>
            <link>http://www.medworm.com/index.php?rid=5631229&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn111-article04.htm</link>
            <description>Listen Up, New Marketing Grads!

Mobile is the new 'shiny thing' of interest to pharmaceutical marketers. However, most pharma mobile apps that I have seen are pretty mundane as far as marketing/advertising is concerned. What's it going to take to make these apps more interesting and useful? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631229</comments>
            <pubDate>Thu, 26 Jan 2012 15:44:34 +0100</pubDate>
            <guid isPermaLink="false">5631229</guid>        </item>
        <item>
            <title>Novo Nordisk Defends Choice of Paula Deen as Diabetes Spokesperson</title>
            <link>http://www.medworm.com/index.php?rid=5631226&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn111-article01.htm</link>
            <description>Unless you are living under a rock on the Moon, you've probably heard that Novo Nordisk has teamed up with celebrity Southern-style chef Paula Deen as a paid spokesperson. 

Ambre Morley, Associate Director, Product Communications, Novo Nordisk, answers questions about why her company teamed up with Deen as a diabetes spokesperson. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631226</comments>
            <pubDate>Thu, 26 Jan 2012 15:44:09 +0100</pubDate>
            <guid isPermaLink="false">5631226</guid>        </item>
        <item>
            <title>FDA Social Media Guidelines May Be Moot</title>
            <link>http://www.medworm.com/index.php?rid=5631228&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn111-article03.htm</link>
            <description>This article presents the relevant case information. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631228</comments>
            <pubDate>Thu, 26 Jan 2012 15:43:45 +0100</pubDate>
            <guid isPermaLink="false">5631228</guid>        </item>
        <item>
            <title>FDA Guidance on Responding to Unsolicited Requests for Off-Label Information</title>
            <link>http://www.medworm.com/index.php?rid=5631227&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn111-article02.htm</link>
            <description>This article takes a closer look at how the off-label guidelines apply to social media such as Youtube, Blogs, and Twitter. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631227</comments>
            <pubDate>Thu, 26 Jan 2012 15:42:44 +0100</pubDate>
            <guid isPermaLink="false">5631227</guid>        </item>
        <item>
            <title>Proposed Rules for Physician Payment Sunshine Act</title>
            <link>http://www.medworm.com/index.php?rid=5527946&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1019-article01.htm</link>
            <description>This article reviews the strategic implications of the Sunshine Act and also presents highlights of the draft regulations rule released by the Centers for Medicare and Medicaid Services on December 15, 2011. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527946</comments>
            <pubDate>Wed, 21 Dec 2011 12:25:33 +0100</pubDate>
            <guid isPermaLink="false">5527946</guid>        </item>
        <item>
            <title>Checking Under the Hood of Pharma Mobile Apps</title>
            <link>http://www.medworm.com/index.php?rid=5527949&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1019-article04.htm</link>
            <description>Let's look 'under the hoods' of two pharma-sponsored mobile apps and compare disclaimers. We'll compare Janssen's PASI calculator, which has an update disclaimer, with the new AFib Educator 2.0 app developed by Sanofi-Aventis. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527949</comments>
            <pubDate>Wed, 21 Dec 2011 12:25:28 +0100</pubDate>
            <guid isPermaLink="false">5527949</guid>        </item>
        <item>
            <title>Politics Vs. Science in the Plan B Decision</title>
            <link>http://www.medworm.com/index.php?rid=5527948&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1019-article03.htm</link>
            <description>HHS Secretary Sebelius focused on the fact that Teva's study did not contain data for all ages for which this product would be available for use. According to Tina Raine-Bennett, MD, MPH, of the Women's Health Research Institute at Kaiser Permanente Northern California, a principal investigator of the University of California-San Francisco study, it is unreasonable and virtually impossible to study the use of emergency contraception in 11- and 12-year-olds, because only a small fraction of them will have had sex by that age. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527948</comments>
            <pubDate>Wed, 21 Dec 2011 12:25:05 +0100</pubDate>
            <guid isPermaLink="false">5527948</guid>        </item>
        <item>
            <title>Certain Physician-Drug Industry Relationships Have Declined Dramatically</title>
            <link>http://www.medworm.com/index.php?rid=5527947&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1019-article02.htm</link>
            <description>The authors of a physician survey published in the of Archives of Internal Medicine conclude 'given that 83.8% of physicians have PIRs, it is clear that industry still has substantial financial links with the nation's physicians. These findings support the ongoing need for a national system of disclosure of PIRs [Physician-Drug Industry Relationships].' Such a system is part of the Physician Sunshine Law, which is scheduled to go into effect in 2012 with public disclosure of payments scheduled to begin September, 2013. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527947</comments>
            <pubDate>Wed, 21 Dec 2011 12:24:33 +0100</pubDate>
            <guid isPermaLink="false">5527947</guid>        </item>
        <item>
            <title>Are Pharma Sales Reps Service Employees?</title>
            <link>http://www.medworm.com/index.php?rid=5460741&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1018-article06.htm</link>
            <description>The Supreme Court has agreed to decide whether drug companies have to pay their sales representatives for working overtime hours. The question before the court in case CHRISTOPHER V. SMITHKLINE BEECHAM CORP is whether or not pharmaceutical sales representatives are exempt from overtime pay under the &quot;outside sales&quot; exemption of the Fair Labor Standards Act of 1938. If the Supreme Court rules that pharma sales reps are NOT exempt, some sales reps worry that they will become &quot;service&quot; employees similar to UPS/Fed Ex delivery people. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460741</comments>
            <pubDate>Thu, 01 Dec 2011 17:30:18 +0100</pubDate>
            <guid isPermaLink="false">5460741</guid>        </item>
        <item>
            <title>Deconstructing Pitts' Guiding Principles for Pharma Social Media</title>
            <link>http://www.medworm.com/index.php?rid=5460740&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1018-article05.htm</link>
            <description>This article takes a closer, critical look at &quot;Pitts' Principles&quot; and discusses how successful the pharma industry has been at following these principles to date. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460740</comments>
            <pubDate>Thu, 01 Dec 2011 17:29:19 +0100</pubDate>
            <guid isPermaLink="false">5460740</guid>        </item>
        <item>
            <title>The Digital Life of Doctors</title>
            <link>http://www.medworm.com/index.php?rid=5460736&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1018-article01.htm</link>
            <description>While primary care physicians in general are frequent users of the Internet, oncologists see online sources of information as more important than PCPs and therefore may need less personal contact to learn about products. That was just one of the results from the 2011 Digital Life survey of 1,454 physicians summarized is this article. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460736</comments>
            <pubDate>Thu, 01 Dec 2011 17:27:51 +0100</pubDate>
            <guid isPermaLink="false">5460736</guid>        </item>
        <item>
            <title>Limiting Bias in Commercially Supported CME</title>
            <link>http://www.medworm.com/index.php?rid=5460739&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1018-article04.htm</link>
            <description>Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460739</comments>
            <pubDate>Thu, 01 Dec 2011 17:26:56 +0100</pubDate>
            <guid isPermaLink="false">5460739</guid>        </item>
        <item>
            <title>The Changing Pharma eDetailing Landscape</title>
            <link>http://www.medworm.com/index.php?rid=5460738&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1018-article03.htm</link>
            <description>A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460738</comments>
            <pubDate>Thu, 01 Dec 2011 17:24:22 +0100</pubDate>
            <guid isPermaLink="false">5460738</guid>        </item>
        <item>
            <title>Pfizer Battles to Protect Lipitor Cash Cow</title>
            <link>http://www.medworm.com/index.php?rid=5460737&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1018-article02.htm</link>
            <description>Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5460737</comments>
            <pubDate>Thu, 01 Dec 2011 17:23:49 +0100</pubDate>
            <guid isPermaLink="false">5460737</guid>        </item>
        <item>
            <title>Are Pharma Reps Important to Docs or Not?</title>
            <link>http://www.medworm.com/index.php?rid=5391481&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1017-article06.htm</link>
            <description>One survey says yes, pharma reps are important to physicians, another says not so much. Who are we to believe? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391481</comments>
            <pubDate>Thu, 10 Nov 2011 19:31:49 +0100</pubDate>
            <guid isPermaLink="false">5391481</guid>        </item>
        <item>
            <title>Maximizing Stakeholder Effectiveness</title>
            <link>http://www.medworm.com/index.php?rid=5391476&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.pharma-mkting.com%2Fnews%2Fpmn1017-article01.htm</link>
            <description>A summary of the highly anticipated 2011 results of Kantar Health's annual Stakeholder Effectiveness survey, which revealed that over two-thirds of respondents from leading companies in the pharmaceutical sector think that customer retention is a key performance measure. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391476</comments>
            <pubDate>Thu, 10 Nov 2011 19:31:47 +0100</pubDate>
            <guid isPermaLink="false">5391476</guid>        </item>
        <item>
            <title>Pharma Turns Up Heat to Unchill Off-Label &quot;Free Speech&quot;</title>
            <link>http://www.medworm.com/index.php?rid=5391480&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.pharma-mkting.com%2Fnews%2Fpmn1017-article05.htm</link>
            <description>The drug industry brings legal heat to the issue of off-label drug promotion. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391480</comments>
            <pubDate>Thu, 10 Nov 2011 19:31:16 +0100</pubDate>
            <guid isPermaLink="false">5391480</guid>        </item>
        <item>
            <title>Pharma YouTube Patient Videos Lack Transparency</title>
            <link>http://www.medworm.com/index.php?rid=5391479&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1017-article04.htm</link>
            <description>Pharma social networking sites like Facebook and YouTube may lack patient-centered information and can also be sources of misleading information that could potentially do more harm than good. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391479</comments>
            <pubDate>Thu, 10 Nov 2011 19:30:46 +0100</pubDate>
            <guid isPermaLink="false">5391479</guid>        </item>
        <item>
            <title>Pfizer's Chapstick Slapstick Facebook Fiasco</title>
            <link>http://www.medworm.com/index.php?rid=5391478&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1017-article03.htm</link>
            <description>If pharma marketers are going to be successful engaging consumers (mostly women) via social media, then they need to be more sensitive about how they portray women in ads and very savvy about how they handle comments (if they allow comments). (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391478</comments>
            <pubDate>Thu, 10 Nov 2011 19:30:02 +0100</pubDate>
            <guid isPermaLink="false">5391478</guid>        </item>
        <item>
            <title>Johnson &amp; Johnson's ennTV</title>
            <link>http://www.medworm.com/index.php?rid=5391477&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1017-article02.htm</link>
            <description>A conversation with Michael Heinley, Corporate Vice President, Leadership and Employee Communication, and Bill Price, Vice President, Media Relations, Johnson &amp; Johnson, about the company's Employee News Network (&quot;ennTV&quot;), a new video news magazine produced for J&amp;J employees worldwide. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391477</comments>
            <pubDate>Thu, 10 Nov 2011 19:29:17 +0100</pubDate>
            <guid isPermaLink="false">5391477</guid>        </item>
        <item>
            <title>Everything You Need to Know About Mobile Platforms</title>
            <link>http://www.medworm.com/index.php?rid=5367752&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.pharma-mkting.com%2Fnews%2Fpmn1016-article01.htm</link>
            <description>If you're thinking of developing a mobile application (app) for patients or physicians, you need to consider the myriad platforms -- hardware plus software combinations -- that are out there and determine which platform is best suited for your intended audience. Your choice of platform will impact your app's performance, maintenance, and security, which in turn will make or break the success of the app. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367752</comments>
            <pubDate>Thu, 27 Oct 2011 18:57:47 +0100</pubDate>
            <guid isPermaLink="false">5367752</guid>        </item>
        <item>
            <title>Antidepressants: Top Advertised &amp; 3rd Most Commonly Used Rx Drug</title>
            <link>http://www.medworm.com/index.php?rid=5367757&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1016-article06.htm</link>
            <description>According to a recent CDC Data Brief, antidepressants were the third most common prescription drug taken by Americans of all ages in 2005–2008 and the most frequently used by persons aged 18–44 years. From 1988–1994 through 2005–2008, the rate of antidepressant use in the United States among all ages increased nearly 400%. Perhaps not so coincidentally, antidepressants are among the TOP advertised Rx category in 2010, according to the recent AdAge analysis. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367757</comments>
            <pubDate>Thu, 27 Oct 2011 18:57:41 +0100</pubDate>
            <guid isPermaLink="false">5367757</guid>        </item>
        <item>
            <title>Without Free Gifts from Pharma to Docs, Would Research be Useless?</title>
            <link>http://www.medworm.com/index.php?rid=5367756&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.pharma-mkting.com%2Fnews%2Fpmn1016-article05.htm</link>
            <description>In a recent blog post, PhRMA said 'Without Promotion Research will be Useless.' To support its case, PhRMA cited 'an interesting opinion editorial' in the latest edition of the Annals of Emergency Medicine. In the op-ed, Emory University economist Paul Rubin, Ph.D. expressed concern that ACEP policy regarding Gifts to Emergency Physicians from Industry 'could have the unfortunate effect of limiting the exchange of critical information between medicine makers and physicians about the benefits and risks of new medicines, how to use them properly and how best to diagnose the right candidates for particular treatments.' (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367756</comments>
            <pubDate>Thu, 27 Oct 2011 18:56:22 +0100</pubDate>
            <guid isPermaLink="false">5367756</guid>        </item>
        <item>
            <title>Is There an Upward Career Path for Pharma Social Media Pioneers?</title>
            <link>http://www.medworm.com/index.php?rid=5367755&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1016-article04.htm</link>
            <description>Are we witnessing an exodus of social media &quot;pioneers&quot; from pharma similar to the exodus of interactive pioneers back at the turn of the century? That last exodus presaged the infamous &quot;dotcom&quot; bust. Perhaps the current exodus presages a similar setback for the social media industry. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367755</comments>
            <pubDate>Thu, 27 Oct 2011 18:54:50 +0100</pubDate>
            <guid isPermaLink="false">5367755</guid>        </item>
        <item>
            <title>Double Dip in DTC Ad Spend!</title>
            <link>http://www.medworm.com/index.php?rid=5367754&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1016-article03.htm</link>
            <description>Direct-to-Consumer (DTC) pharmaceutical advertising spending suffered a 'double dip' recession between 2007 and 2010, according to data presented in the AdAge Insights Whitepaper &quot;Pharmaceutical Marketing: Targeting Consumers &amp; Connecting Online.&quot; Spending dipped 14% from a high of $5.4 billion in 2006 to $4.7 billion in 2008 and dipped again 9% in 2010 compared to 2009, which saw a modest 2.4% increase over 2008. Meanwhile, Internet display ad spending by top pharma advertisers decreased 33% in 2010 compared to 2009. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367754</comments>
            <pubDate>Thu, 27 Oct 2011 18:54:13 +0100</pubDate>
            <guid isPermaLink="false">5367754</guid>        </item>
        <item>
            <title>How to Score With Women (as a Marketer) via Social Media</title>
            <link>http://www.medworm.com/index.php?rid=5367753&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1016-article02.htm</link>
            <description>A conversation with Casey Quinlan, 'Mighty Mouth' at Mighty Casey Media LLC, Zoe Dunn, Principal, Hale Advisors, Richard Meyer, Principal Consultant, Online Strategic Solutions, Jerry Hall, Digital Media Executive, Advisor to Pearescope, about engaging and marketing to women online, especially via social media, which some new media marketers claim is 'all about women.' (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5367753</comments>
            <pubDate>Thu, 27 Oct 2011 18:53:43 +0100</pubDate>
            <guid isPermaLink="false">5367753</guid>        </item>
        <item>
            <title>Physician Participation in Peer-to-Peer Social Media Sites</title>
            <link>http://www.medworm.com/index.php?rid=5306904&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.pharma-mkting.com%2Fnews%2Fpmn1015-article01.htm</link>
            <description>This article summaries research data exploring why physicians interested in using online peer-to-peer social communities outnumber by 2 to 1 physicians who are actually using them. Includes suggestions for what these communities must do in order to provide more value to physicians. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5306904</comments>
            <pubDate>Wed, 12 Oct 2011 17:52:39 +0100</pubDate>
            <guid isPermaLink="false">5306904</guid>        </item>
        <item>
            <title>PhRMA Masters the Art of &quot;Proofiness!&quot;</title>
            <link>http://www.medworm.com/index.php?rid=5306908&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.pharma-mkting.com%2Fnews%2Fpmn1015-article05.htm</link>
            <description>In a recent video titled 'What Gets PhRMA's Chairman Up Every Morning?', Chris Viehbacher, CEO of Sanofi, cited an impressive Potemkin number related to life expectancy and the pharma industry. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5306908</comments>
            <pubDate>Wed, 12 Oct 2011 17:52:33 +0100</pubDate>
            <guid isPermaLink="false">5306908</guid>        </item>
        <item>
            <title>The Big C in the Big Apple</title>
            <link>http://www.medworm.com/index.php?rid=5306907&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1015-article04.htm</link>
            <description>HepC.tv is featuring the video 'Man-on-the-Street: New Yorkers' Reactions to the Big Yellow C.' Is it effective? How do we know? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5306907</comments>
            <pubDate>Wed, 12 Oct 2011 17:51:41 +0100</pubDate>
            <guid isPermaLink="false">5306907</guid>        </item>
        <item>
            <title>In Memory of Steve Jobs Will Novartis Sales Reps Really Embrace iPads?</title>
            <link>http://www.medworm.com/index.php?rid=5306906&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1015-article03.htm</link>
            <description>David Epstein, head of Novartis Pharmaceuticals, said eighty percent of his company's sales reps will give up their PCs for iPads in 2012. Will they do it? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5306906</comments>
            <pubDate>Wed, 12 Oct 2011 17:51:06 +0100</pubDate>
            <guid isPermaLink="false">5306906</guid>        </item>
        <item>
            <title>The Pozen Digital Advisory Board</title>
            <link>http://www.medworm.com/index.php?rid=5306905&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1015-article02.htm</link>
            <description>A conversation with Elizabeth A. Cermak, EVP, and Chief Commercial Officerat Pozen, Raj Amin, CEO and Co-Founder of HealthiNation, and Bonin Bough, Senior Global Director of Digital and Social Media, PepsiCo, about the who, what, why behind the Pozen Digital Advisory Board, an esteemed group of digital thought-leaders both in and outside of healthcare. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5306905</comments>
            <pubDate>Wed, 12 Oct 2011 17:50:28 +0100</pubDate>
            <guid isPermaLink="false">5306905</guid>        </item>
        <item>
            <title>Boehringer vs Facebook Social Media Socialism</title>
            <link>http://www.medworm.com/index.php?rid=5253687&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1014-article01.htm</link>
            <description>Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253687</comments>
            <pubDate>Thu, 22 Sep 2011 20:58:39 +0100</pubDate>
            <guid isPermaLink="false">5253687</guid>        </item>
        <item>
            <title>Pharma's Physician Bailout</title>
            <link>http://www.medworm.com/index.php?rid=5253690&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1014-article04.htm</link>
            <description>The pharmaceutical industry has been very generous in making payments to physicians. Last year (2010), for example, a mere dozen pharmaceutical companies paid $760 million to physicians and other health care providers for consulting, speaking, research and expenses. On average, how much do you think that comes to for every physician in the U.S.? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253690</comments>
            <pubDate>Thu, 22 Sep 2011 20:58:36 +0100</pubDate>
            <guid isPermaLink="false">5253690</guid>        </item>
        <item>
            <title>Orphan Drugs Now &quot;Where the Money Is,&quot; Says Willie Sutton's Ghost</title>
            <link>http://www.medworm.com/index.php?rid=5253689&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1014-article03.htm</link>
            <description>Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253689</comments>
            <pubDate>Thu, 22 Sep 2011 20:58:03 +0100</pubDate>
            <guid isPermaLink="false">5253689</guid>        </item>
        <item>
            <title>New Big Pharma Economies of Scale</title>
            <link>http://www.medworm.com/index.php?rid=5253688&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1014-article02.htm</link>
            <description>How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5253688</comments>
            <pubDate>Thu, 22 Sep 2011 20:57:32 +0100</pubDate>
            <guid isPermaLink="false">5253688</guid>        </item>
        <item>
            <title>British Pharma Digital Update</title>
            <link>http://www.medworm.com/index.php?rid=5149534&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1013-article01.htm</link>
            <description>This article reports the results of an informal Weber Shandwick survey regarding social media guidelines recently published by the British pharmaceutical industry regulators. Includes advice on how to innovate online without waiting for more specific guidelines from regulators. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5149534</comments>
            <pubDate>Wed, 24 Aug 2011 14:30:20 +0100</pubDate>
            <guid isPermaLink="false">5149534</guid>        </item>
        <item>
            <title>Four Useful Lessons Pharma Can Learn from the Pfizer Facebook Hack</title>
            <link>http://www.medworm.com/index.php?rid=5149536&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1013-article02.htm</link>
            <description>Pfizer's US corporate Facebook page was &quot;hacked&quot; by some &quot;Kiddies.&quot; What should the industry learn from this experience? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5149536</comments>
            <pubDate>Tue, 23 Aug 2011 13:08:59 +0100</pubDate>
            <guid isPermaLink="false">5149536</guid>        </item>
        <item>
            <title>Pharma Facebook Pages Being Phased Out: A Good Run While It Lasted!</title>
            <link>http://www.medworm.com/index.php?rid=5149538&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1013-article04.htm</link>
            <description>No doubt you've heard that as of August 15, 2011, Facebook opened up comments on ALL pharma pages with some exceptions. That means that the pharmaceutical industry will no longer be able to shut off comments on their Facebook pages. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5149538</comments>
            <pubDate>Tue, 23 Aug 2011 13:06:05 +0100</pubDate>
            <guid isPermaLink="false">5149538</guid>        </item>
        <item>
            <title>PR &amp; Interactive Agencies Vie for Pharma Social Media Campaign Crumbs</title>
            <link>http://www.medworm.com/index.php?rid=5149537&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1013-article03.htm</link>
            <description>Should a PR firm or an interactive marketing agency be in charge of pharma social media campaigns? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5149537</comments>
            <pubDate>Tue, 23 Aug 2011 13:06:01 +0100</pubDate>
            <guid isPermaLink="false">5149537</guid>        </item>
        <item>
            <title>Vast Majority of Drug Ads in Leading Medical Journals Don't Pass MDs' Sniff Test!</title>
            <link>http://www.medworm.com/index.php?rid=5149535&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1013-article05.htm</link>
            <description>A study led by Mount Sinai School of Medicine researchers of 192 pharmaceutical advertisements (83 full unique advertisements) in biomedical journals found that only 18 percent (15) were compliant with Food and Drug Administration (FDA) guidelines, and over half failed to quantify serious risks including death. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5149535</comments>
            <pubDate>Tue, 23 Aug 2011 13:04:02 +0100</pubDate>
            <guid isPermaLink="false">5149535</guid>        </item>
        <item>
            <title>The Digital Health Coalition</title>
            <link>http://www.medworm.com/index.php?rid=5043470&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.talk.pharma-mkting.com%2Fshow142.htm</link>
            <description>Solving Real Problems -- Mission Possible?

A conversation with Mark Bard, founder of the Digital Health Coalition, regarding the mission of the Coalition and what companies and individuals are involved. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5043470</comments>
            <pubDate>Thu, 21 Jul 2011 17:12:16 +0100</pubDate>
            <guid isPermaLink="false">5043470</guid>        </item>
        <item>
            <title>Adobe Connect for eDetailing</title>
            <link>http://www.medworm.com/index.php?rid=5043469&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1012-article01.htm</link>
            <description>This article focuses on Adobe Connect for eDetailing, a specific collaboration between Adobe and ConnectSolutions, a leading provider of private cloud deployments of web conferencing and collaboration solutions. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5043469</comments>
            <pubDate>Thu, 21 Jul 2011 17:12:16 +0100</pubDate>
            <guid isPermaLink="false">5043469</guid>        </item>
        <item>
            <title>SURVEY: Rules for Pharma Engagement in Patient &amp; Physician Social Networks</title>
            <link>http://www.medworm.com/index.php?rid=5043475&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.surveymonkey.com%2Fs%2FCSLCCS3</link>
            <description>How Should Pharma Engage in Patient/Physician Social Networks?

Should owners and operators of online discussion sites -- whether they be independent corporations such as Sermo, or hospitals, other healthcare organizations, and even pharmaceutical companies (someday) -- publish SOCIAL MEDIA POLICIES that comply with as-yet-to-be-determined &quot;fair social media practice principles?&quot; (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5043475</comments>
            <pubDate>Thu, 21 Jul 2011 16:49:44 +0100</pubDate>
            <guid isPermaLink="false">5043475</guid>        </item>
        <item>
            <title>FDA is Monitoring This Blog and Perhaps You Too!</title>
            <link>http://www.medworm.com/index.php?rid=5043474&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2Fpj8ZWO</link>
            <description>he FDA may be using sophisticated monitoring tools to mine the Internet -- including &quot;any website/blog/microblog, social media or online publication&quot; -- that &quot;mentions ... the FDA and special topics of interest to the FDA.&quot; The FDA does not say why it needs to monitor sites that merely &quot;mention&quot; the FDA nor what &quot;special topics&quot; it is interested in. Could it be the agency is getting nervous about all the criticism it is getting for not being very productive in issuing social media guidance? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5043474</comments>
            <pubDate>Thu, 21 Jul 2011 16:48:08 +0100</pubDate>
            <guid isPermaLink="false">5043474</guid>        </item>
        <item>
            <title>Pfizer, Show Us Your Social Media &quot;Playbook&quot;</title>
            <link>http://www.medworm.com/index.php?rid=5043473&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FoHS9Bq</link>
            <description>At a recent conference, Ray Kerins, Vice President of Worldwide Communications at Pfizer, mentioned Pfizer's &quot;groundbreaking internal Social Media Playbook.&quot; When asked outright if there is anything in the playbook that can be made public or if a copy would be made available for review, Kerins said: &quot;NO!&quot; 

Why can't we see it? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5043473</comments>
            <pubDate>Thu, 21 Jul 2011 16:47:32 +0100</pubDate>
            <guid isPermaLink="false">5043473</guid>        </item>
        <item>
            <title>Tracking Public Health Trends</title>
            <link>http://www.medworm.com/index.php?rid=5043472&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fgoo.gl%2F2givz</link>
            <description>Twitter vs Google vs Your Nose

Researchers at the Johns Hopkins Center for Language and Speech Processing have analyzed 2 billion public tweets posted between May 2009 and October 2010 to learn if it is possible to use Twitter to track important public health trends. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5043472</comments>
            <pubDate>Thu, 21 Jul 2011 16:46:44 +0100</pubDate>
            <guid isPermaLink="false">5043472</guid>        </item>
        <item>
            <title>Citizen Petition Likely to Delay FDA Social Media Guidance</title>
            <link>http://www.medworm.com/index.php?rid=5043471&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2Frl8sZB</link>
            <description>Six major pharmaceutical companies filed a &quot;citizen petition&quot; with the FDA, urging the agency to &quot;establish comprehensive, clear and binding regulations to guide the industry&quot; in communicating off-label drug information to physicians and payers. This petition is likely to delay social media guidance from the FDA. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5043471</comments>
            <pubDate>Thu, 21 Jul 2011 16:46:09 +0100</pubDate>
            <guid isPermaLink="false">5043471</guid>        </item>
        <item>
            <title>The Pharmaguy Social Media Timeline</title>
            <link>http://www.medworm.com/index.php?rid=4916327&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1010-article01.htm</link>
            <description>A Unique Record of Social Media Events Impacting the Pharmaceutical Industry

The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline&amp;trade; now, at a time when the industry already has set precedents in every social media application. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4916327</comments>
            <pubDate>Thu, 09 Jun 2011 10:12:06 +0100</pubDate>
            <guid isPermaLink="false">4916327</guid>        </item>
        <item>
            <title>First FDA Social Media Guidance to Address Responding to &quot;Unsolicited Requests&quot; for Off-label Information</title>
            <link>http://www.medworm.com/index.php?rid=4906961&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fgoo.gl%2FgPKus</link>
            <description>Why did the FDA put &quot;Responding to Unsolicited Requests&quot; at the TOP of its list of &quot;issues related to Internet/social media promotion of FDA-regulated medical products&quot; for which it promises to issue guidance in 2011? 

Where did that issue arise? It wasn't mentioned in the Federal Register and there was only one mention of &quot;unsolicited&quot; in presentations made at the November, 2009 public hearing. That presentation put forward a social media off-label user-generated content scenario for which the FDA might issue guidance in 2011. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4906961</comments>
            <pubDate>Wed, 08 Jun 2011 12:41:43 +0100</pubDate>
            <guid isPermaLink="false">4906961</guid>        </item>
        <item>
            <title>The Pharmaguy Social Media Timeline&amp;trade</title>
            <link>http://www.medworm.com/index.php?rid=4906956&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn1010-article01.htm</link>
            <description>A Unique Record of Social Media Events Impacting the Pharmaceutical Industry

The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline&amp;trade; now, at a time when the industry already has set precedents in every social media application. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4906956</comments>
            <pubDate>Wed, 08 Jun 2011 12:40:33 +0100</pubDate>
            <guid isPermaLink="false">4906956</guid>        </item>
        <item>
            <title>FDA Drops &quot;Social Media&quot; from Its 2011 Guidance Agenda</title>
            <link>http://www.medworm.com/index.php?rid=4906960&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fgoo.gl%2FIaxCm</link>
            <description>Missing from the &quot;Guidance Agenda: New &amp; Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2011&quot; is &quot;Promotion of Prescription Drug Products Using Social Media Tools&quot;, which WAS on the 2010 Agenda. 

What's up with that? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4906960</comments>
            <pubDate>Wed, 08 Jun 2011 12:40:05 +0100</pubDate>
            <guid isPermaLink="false">4906960</guid>        </item>
        <item>
            <title>FDA, DOJ, &amp; Google: Conspiracy Theory, Part 2</title>
            <link>http://www.medworm.com/index.php?rid=4906959&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fgoo.gl%2F2givz</link>
            <description>FDA was involved in the criminal investigation of Google by the Department of Justice (DOJ). 

In light of that, was FDA's infamous 14 warning letters sent to major pharma companies regarding violative search engine ads a &quot;shot across Googles bow,&quot; intended to force Google to halt its acceptance of ads from &quot;illegal&quot; online pharmacies? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4906959</comments>
            <pubDate>Wed, 08 Jun 2011 12:39:22 +0100</pubDate>
            <guid isPermaLink="false">4906959</guid>        </item>
        <item>
            <title>New Facebook Policy &quot;Kind of Hurts&quot; Pharma Marketers</title>
            <link>http://www.medworm.com/index.php?rid=4906958&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fgoo.gl%2FISCcy</link>
            <description>An official Facebook statement says: 

&quot;In an effort to encourage conversations between brands and people, we recently made some changes to our policies that affect some official pharmaceutical pages directed at building communities. This change does not affect pages for prescription drugs. We think these changes will help encourage an authentic dialogue on pages.&quot; (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4906958</comments>
            <pubDate>Wed, 08 Jun 2011 12:37:37 +0100</pubDate>
            <guid isPermaLink="false">4906958</guid>        </item>
        <item>
            <title>Finding the Consumer Within the Patient</title>
            <link>http://www.medworm.com/index.php?rid=4906957&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.talk.pharma-mkting.com%2Fshow140.htm</link>
            <description>Insights Into How Healthcare Decisions are Made

A conversation with Grace Soyao, Founder &amp; Chief Strategy Officer of Self Care Catalysts Inc., a health research and strategy company, about her company's unique and proprietary processes and tools specifically designed using health psychology to understand how today's patients/healthcare consumers make healthcare decisions. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4906957</comments>
            <pubDate>Wed, 08 Jun 2011 12:36:46 +0100</pubDate>
            <guid isPermaLink="false">4906957</guid>        </item>
        <item>
            <title>Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?</title>
            <link>http://www.medworm.com/index.php?rid=4835279&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn109-article01.htm</link>
            <description>This article discusses the regulatory and other issues associated with pharma developed or sponsored health apps. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4835279</comments>
            <pubDate>Wed, 18 May 2011 17:57:15 +0100</pubDate>
            <guid isPermaLink="false">4835279</guid>        </item>
        <item>
            <title>Physicians Are Concerned That Pharma Supported CME is Biased, But ...</title>
            <link>http://www.medworm.com/index.php?rid=4835283&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2Fcmebias</link>
            <description>Commercial funding of continuing medical education (CME) and the potential for bias appear to concern many physicians, yet only a TINY MINORITY (7%) are willing to pay registration fees to eliminate or offset commercial funding sources, according to a report in the May 9 issue of Archives of Internal Medicine. Find more results of the survey here. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4835283</comments>
            <pubDate>Wed, 18 May 2011 17:56:42 +0100</pubDate>
            <guid isPermaLink="false">4835283</guid>        </item>
        <item>
            <title>eDetailing Technology &amp; Birth of &quot;Sales Cyborg&quot;</title>
            <link>http://www.medworm.com/index.php?rid=4835282&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2Frepcyborg</link>
            <description>&quot;Big pharmaceutical companies have found replacements for the army of sales representatives they've laid off in recent years: digital sales tools that seek to sell doctors on drugs without the intrusion of an office visit,&quot; says the WSJ. Some sales reps may morph into what could be called &quot;sales cyborgs&quot; who engage in remote live human conversations with physicians aided by technology. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4835282</comments>
            <pubDate>Wed, 18 May 2011 17:56:06 +0100</pubDate>
            <guid isPermaLink="false">4835282</guid>        </item>
        <item>
            <title>FDA's BadAd Program Lacks Credible Evidence</title>
            <link>http://www.medworm.com/index.php?rid=4835284&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FBadAdlack</link>
            <description>A recent FDA notice of violation letter resulting from its BadAd program reads like charges made by a prosecutor at a criminal trial except there's no trial. And there's no credible evidence such as violative detail aids, brochures, etc! Read more, including the letter here. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4835284</comments>
            <pubDate>Wed, 18 May 2011 17:54:49 +0100</pubDate>
            <guid isPermaLink="false">4835284</guid>        </item>
        <item>
            <title>FDA v. Google &amp; Those 14 Infamous Warning Letters</title>
            <link>http://www.medworm.com/index.php?rid=4835281&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2Fgoogconspire</link>
            <description>Ready for a good conspiracy theory? FDA's Infamous 14 Warning Letters Regarding Search Ads were a Ploy to Force Google into a $500M DOJ Settlement of a Case Involving Illegal Online Pharmacy Ads. FDA's warning letters may have been a &quot;shot across Google's bow,&quot; intended to force Google to halt its acceptance of ads from &quot;illegal&quot; online pharmacies. Read the full conspiracy theory here (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4835281</comments>
            <pubDate>Wed, 18 May 2011 17:54:05 +0100</pubDate>
            <guid isPermaLink="false">4835281</guid>        </item>
        <item>
            <title>Challenges of Regulating Mobile Medical Apps</title>
            <link>http://www.medworm.com/index.php?rid=4835280&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.talk.pharma-mkting.com%2Fshow137.htm</link>
            <description>Legal and Regulatory Issues You Should Know About. A conversation with Joseph Kim, MD, MPH, VP of Medical Affairs and Technology at Medical Communications Media, Inc., about the rapid development of mobile medical applications and the legal and regulatory issues that physicians, patients, and pharma developers/sponsors should be aware of. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4835280</comments>
            <pubDate>Wed, 18 May 2011 17:52:24 +0100</pubDate>
            <guid isPermaLink="false">4835280</guid>        </item>
        <item>
            <title>SURVEY: Potential for Bias in Commercially Supported CME</title>
            <link>http://www.medworm.com/index.php?rid=4808330&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.surveymonkey.com%2Fs%2FPQ3VCML</link>
            <description>Please take 2 minutes to answer a few short questions relating to potential bias in continuing medical education (CME) programs supported by pharma/medical device companies and how to limit the need for industry funding of CME. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4808330</comments>
            <pubDate>Tue, 10 May 2011 10:59:12 +0100</pubDate>
            <guid isPermaLink="false">4808330</guid>        </item>
        <item>
            <title>SURVEY: Use of Twitter by Pharma Company Employees</title>
            <link>http://www.medworm.com/index.php?rid=4765243&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.surveymonkey.com%2Fs%2F3T5ZYYN</link>
            <description>More and more pharmaceutical company employees are using Twitter. Many are using personal Twitter accounts and some also are responsible for corporate Twitter accounts. These employees can be influential ambassadors among the public and have an opportunity -- maybe even a responsibility -- to help improve the company's reputation. Please complete this survey and indicate which Pharmaguy Twitter Pioneers you follow and to provide your opinions about the use of Twitter by the drug industry and by employees of the industry. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4765243</comments>
            <pubDate>Fri, 29 Apr 2011 21:04:14 +0100</pubDate>
            <guid isPermaLink="false">4765243</guid>        </item>
        <item>
            <title>Physicians Favor Brands With a Compelling Adherence Program</title>
            <link>http://www.medworm.com/index.php?rid=4765238&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn108-article01.htm</link>
            <description>This article summarizes the results of a survey of physicians designed to assess the value of various adherence solutions -- including HealthPrize -- and the potential of these solutions to influence physicians' prescribing behavior. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4765238</comments>
            <pubDate>Fri, 29 Apr 2011 21:01:26 +0100</pubDate>
            <guid isPermaLink="false">4765238</guid>        </item>
        <item>
            <title>FDA's Bad Ad Program is &quot;Phoniest Thing Ever!&quot;</title>
            <link>http://www.medworm.com/index.php?rid=4765242&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FBadAdProg</link>
            <description>So says Jerry Roth, president of Sanford, Fla.-based Hill Dermaceuticals. His company received the ONLY letter from the FDA as as a result of a complaint received via DDMAC's (Division of Drug Marketing, Advertising, and Communication) Bad Ad Program. Mr Roth claims DDMAC acted on a complaint filed by &quot;a doctor for another [competing] company,&quot; which is interesting because so many -- perhaps up to 80% -- of &quot;prescribers&quot; are employed directly or indirectly by pharmaceutical companies. Is the BadAd program biased, ineffective, not worth the cost? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4765242</comments>
            <pubDate>Thu, 28 Apr 2011 21:01:56 +0100</pubDate>
            <guid isPermaLink="false">4765242</guid>        </item>
        <item>
            <title>FDA Plans to Test New Standard for Easy to Understand Rx Labels</title>
            <link>http://www.medworm.com/index.php?rid=4765241&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FEasyLabel</link>
            <description>In an effort to make Rx drug package inserts easier to read and understand -- and perhaps to save money on printing costs -- the FDA is planning to test single-page consumer information sheets that would replace the multi-page package inserts and medication guides widely used in retail pharmacies. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4765241</comments>
            <pubDate>Thu, 28 Apr 2011 21:01:08 +0100</pubDate>
            <guid isPermaLink="false">4765241</guid>        </item>
        <item>
            <title>A New Estimate of Drug Development Cost</title>
            <link>http://www.medworm.com/index.php?rid=4765240&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FNewEstimate</link>
            <description>A conversation with Jacqueline Thong, co-founder and CEO of Ubiqi Health, about disease management mobile applications and how pharma marketers can leverage mobile health apps to engage with and learn from patients. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4765240</comments>
            <pubDate>Thu, 28 Apr 2011 21:00:29 +0100</pubDate>
            <guid isPermaLink="false">4765240</guid>        </item>
        <item>
            <title>Implications of Facebook's Page Commenting Changes</title>
            <link>http://www.medworm.com/index.php?rid=4765239&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.talk.pharma-mkting.com%2Fshow135.htm</link>
            <description>Turning Off Comments May Be a Problem. A conversation with Matthew Snodgrass, Social Media Director at WCG, about Facebook's planned changes to its &quot;whitelisting&quot; policy and its implications for pharmaceutical marketers. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4765239</comments>
            <pubDate>Thu, 28 Apr 2011 20:59:49 +0100</pubDate>
            <guid isPermaLink="false">4765239</guid>        </item>
        <item>
            <title>The Changing Role of Pharma Sales Reps</title>
            <link>http://www.medworm.com/index.php?rid=4728293&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn107-article01.htm</link>
            <description>This article is a summary of an interview of Nancy Lurker, CEO of PDI, Inc., which provides promotional outsourced services to healthcare companies. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4728293</comments>
            <pubDate>Sun, 17 Apr 2011 13:15:28 +0100</pubDate>
            <guid isPermaLink="false">4728293</guid>        </item>
        <item>
            <title>Brits Beat FDA &amp; PhRMA: Issue Social Media Guidance for Pharma</title>
            <link>http://www.medworm.com/index.php?rid=4728294&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPMBBritsvFDA</link>
            <description>The Brits have won the race to issue social media guidance for the drug industry! The Prescription Medicines Code of Practice Authority (PMCPA), which oversees the self-regulatory code of the Association of the British Pharmaceutical Industry (ABPI), just published &quot;informal guidance&quot; providing the drug industry advice on how to use online communications. Read this article to learn more about these guidelines. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4728294</comments>
            <pubDate>Fri, 15 Apr 2011 13:15:14 +0100</pubDate>
            <guid isPermaLink="false">4728294</guid>        </item>
        <item>
            <title>Phil Mickelson is Now Regulated by FDA</title>
            <link>http://www.medworm.com/index.php?rid=4728297&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPMBPhilFDAapproved</link>
            <description>Recall that last summer Phil Mickelson was quoted in the press as saying he was treating his Psoriatic Arthritis with ENBREL. He was also quoted as saying: &quot;I have no aches and pains. My back feels great. I feel stronger and more flexible than I've ever been.&quot; Now that he is featured in ENBREL TV ads, his commercial speech is regulated by the FDA. What is he allowed to say now about his treatment? For the answer, read this article. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4728297</comments>
            <pubDate>Fri, 15 Apr 2011 13:13:55 +0100</pubDate>
            <guid isPermaLink="false">4728297</guid>        </item>
        <item>
            <title>Ad Dollars Follow Eyeballs to Web</title>
            <link>http://www.medworm.com/index.php?rid=4728296&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPMBWebAdTrends</link>
            <description>Internet advertising revenue in the United States totaled $26.0 billion for the full year of 2010, whereas ad revenue earned by newspapers was $22.8 billion, according to a PwC/IAB report. Read this article to see more data &amp; charts from this report, plus a &quot;guesstimate&quot; for how much pharma spends on Web advertising. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4728296</comments>
            <pubDate>Fri, 15 Apr 2011 13:13:00 +0100</pubDate>
            <guid isPermaLink="false">4728296</guid>        </item>
        <item>
            <title>Podcast: Mining Mobile Health App User Data</title>
            <link>http://www.medworm.com/index.php?rid=4728295&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPMT134</link>
            <description>A conversation with Jacqueline Thong, co-founder and CEO of Ubiqi Health, about disease management mobile applications and how pharma marketers can leverage mobile health apps to engage with and learn from patients. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4728295</comments>
            <pubDate>Fri, 15 Apr 2011 13:11:50 +0100</pubDate>
            <guid isPermaLink="false">4728295</guid>        </item>
        <item>
            <title>SURVEY: Use of Twitter by Pharma Company Employees</title>
            <link>http://www.medworm.com/index.php?rid=4728298&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPMT132</link>
            <description>More and more pharmaceutical company employees are using Twitter. Many are using personal Twitter accounts and some also are responsible for corporate Twitter accounts. These employees can be influential ambassadors among the public and have an opportunity -- maybe even a responsibility -- to help improve the company's reputation. Please complete this survey and indicate which Pharmaguy Twitter Pioneers you follow and to provide your opinions about the use of Twitter by the drug industry and by employees of the industry. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4728298</comments>
            <pubDate>Fri, 15 Apr 2011 13:10:32 +0100</pubDate>
            <guid isPermaLink="false">4728298</guid>        </item>
        <item>
            <title>Adverse Event Reporting: A Missed Opportunity</title>
            <link>http://www.medworm.com/index.php?rid=4666908&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn106-upfront.htm</link>
            <description>When asked what the # 1 concern pharmaceutical marketers have regarding using social media, the adverse event reporting (AER) boogey man is cited most often. The urge to avoid this boogey man at all costs may have more to do with CEO compensation that with fears of rank-an-file marketers. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4666908</comments>
            <pubDate>Fri, 01 Apr 2011 14:15:20 +0100</pubDate>
            <guid isPermaLink="false">4666908</guid>        </item>
        <item>
            <title>FDA Promises Still More Guidance! This Time It's Mobile.</title>
            <link>http://www.medworm.com/index.php?rid=4666912&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FMedDevApp</link>
            <description>&quot;The Food &amp; Drug Administration is planning to release guidance for mobile medical applications in 2011, according to Center for Devices and Radiological Health director Dr. Jeffrey Shuren.&quot; At issue is kind of mobile medical applications must be approved as medical devices. So far, FDA has approved only two mobile applications. Meanwhile, many pharmaceutical marketers are developing mobile apps such as Janssen's &quot;Psoriasis&quot; app for the iPhone and iPad. Is this app a medical device that requires approval by the FDA? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4666912</comments>
            <pubDate>Wed, 30 Mar 2011 13:15:08 +0100</pubDate>
            <guid isPermaLink="false">4666912</guid>        </item>
        <item>
            <title>Physicians Favor Brands with Compelling Adherence Platform</title>
            <link>http://www.medworm.com/index.php?rid=4666910&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPMT132</link>
            <description>A conversation with Katrina S. Firlik, M.D., Chief Medical Officer, and John Ruvane, Vice President, Sales and Business Development, HealthPrize, highlighting results of an independent physician survey that suggests HealthPrize's patient adherence program can sway physician prescribing preferences. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4666910</comments>
            <pubDate>Wed, 30 Mar 2011 13:14:33 +0100</pubDate>
            <guid isPermaLink="false">4666910</guid>        </item>
        <item>
            <title>Are Sales Reps as &quot;Useful&quot; as PhRMA Wants Us to Believe?</title>
            <link>http://www.medworm.com/index.php?rid=4666911&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPhRMAKRCsurvey</link>
            <description>&quot;New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers&quot; is the main point PhRMA (Pharmaceutical Research and Manufacturing Association - the industry trade association) emphasized in its press release regarding a survey of physicians it sponsored. PhRMA also pointed out that nearly 9 out of 10 physicians considered company-sponsored peer education programs to be &quot;up-to-date, useful and reliable.&quot; What else does the survey reveal about the value of sales reps? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4666911</comments>
            <pubDate>Wed, 30 Mar 2011 13:14:02 +0100</pubDate>
            <guid isPermaLink="false">4666911</guid>        </item>
        <item>
            <title>Pharma TeleWeb e-Detailing</title>
            <link>http://www.medworm.com/index.php?rid=4666909&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn106-article01.htm</link>
            <description>This article summarizes Eli Lilly's European experience using TeleWeb e-detailing, which combines a personal sales rep phone call with Web site surfing. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4666909</comments>
            <pubDate>Wed, 30 Mar 2011 13:12:40 +0100</pubDate>
            <guid isPermaLink="false">4666909</guid>        </item>
        <item>
            <title>Evidence-Based Pharma Marketing</title>
            <link>http://www.medworm.com/index.php?rid=4611959&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPMT130</link>
            <description>For marketing professionals, market access is the key to success. Doctors, payers and consumers are asking for value based on evidence. Being able to prove the value of a particular product may be the best method for increasing sales. Pharma marketing executives need the tools and knowledge necessary to use scientific and health outcomes data for proving product value and gaining market access. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611959</comments>
            <pubDate>Sat, 19 Mar 2011 12:50:23 +0100</pubDate>
            <guid isPermaLink="false">4611959</guid>        </item>
        <item>
            <title>Method Acting for Real Patients</title>
            <link>http://www.medworm.com/index.php?rid=4611960&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FSApatactor</link>
            <description>The pharmaceutical industry can scrap expensive, custom-designed, standalone video Web sites, post videos to YouTube instead, and save money. Even more money can be saved by using real patients in these videos. But can patients be convincing actors? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611960</comments>
            <pubDate>Thu, 10 Mar 2011 13:49:12 +0100</pubDate>
            <guid isPermaLink="false">4611960</guid>        </item>
        <item>
            <title>Pharma Twitter Pioneers Recognized</title>
            <link>http://www.medworm.com/index.php?rid=4611961&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn105-article01.htm</link>
            <description>This article is an introduction to the first round of members of this group. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611961</comments>
            <pubDate>Thu, 10 Mar 2011 13:47:48 +0100</pubDate>
            <guid isPermaLink="false">4611961</guid>        </item>
        <item>
            <title>Will Critics Kill Pharma's Social Media Golden Egg Laying Goose?</title>
            <link>http://www.medworm.com/index.php?rid=4509251&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn104-upfront.htm</link>
            <description>The fear is that if the first steps by pharma to engage in social media conversation are too harshly scrutinized and criticized, the drug industry will shy away from getting more involved in social media. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4509251</comments>
            <pubDate>Wed, 23 Feb 2011 18:42:53 +0100</pubDate>
            <guid isPermaLink="false">4509251</guid>        </item>
        <item>
            <title>Phil Mickelson &quot;Opens Up&quot; to Arthritis Today Magazine</title>
            <link>http://www.medworm.com/index.php?rid=4509254&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FPhilAT</link>
            <description>Top pro golfer Phil Mickelson is featured on the cover and inside story of the Mar-April 2011 issue of Arthritis Today magazine. In the story, Mickelson's remarks are more balanced now that he is a paid ENBREL spokesperson. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4509254</comments>
            <pubDate>Wed, 23 Feb 2011 18:42:34 +0100</pubDate>
            <guid isPermaLink="false">4509254</guid>        </item>
        <item>
            <title>AstraZeneca Hosts &quot;Take on Depression&quot; Facebook Discussion</title>
            <link>http://www.medworm.com/index.php?rid=4509253&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FAZTODpost</link>
            <description>In an ongoing investigation by &quot;Pharma SM Detective&quot;, AstraZeneca's &quot;Take on Depression&quot; FaceBook unbranded discussion application was found to include the &quot;seroquel&quot; brand name in its URL. Further investigation disclosed other interesting aspects of AZ's #TakeonDepression campaign. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4509253</comments>
            <pubDate>Wed, 23 Feb 2011 18:41:38 +0100</pubDate>
            <guid isPermaLink="false">4509253</guid>        </item>
        <item>
            <title>AstraZeneca Hosts Twitter Chat &amp; World Does NOT End!</title>
            <link>http://www.medworm.com/index.php?rid=4509255&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2Frxsavechat</link>
            <description>Despite dire predictions of &quot;PR failure,&quot; the #rxsave Twitter chat hosted by @AstraZenecaUS on 15 February 2011 was a great success, which is pharma social media speak for &quot;did not crash and burn.&quot; (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4509255</comments>
            <pubDate>Wed, 23 Feb 2011 18:41:09 +0100</pubDate>
            <guid isPermaLink="false">4509255</guid>        </item>
        <item>
            <title>Google's New OneBox Rx &quot;Ads&quot; Steal Clicks</title>
            <link>http://www.medworm.com/index.php?rid=4509256&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FGOGLonebox</link>
            <description>Data suggest that Google's OneBox NIH Rx ads &quot;effectively reduces organic search visitation driven to pharma sites pushing the traffic to NIH content instead. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4509256</comments>
            <pubDate>Wed, 23 Feb 2011 18:40:45 +0100</pubDate>
            <guid isPermaLink="false">4509256</guid>        </item>
        <item>
            <title>HCP Marketing Beyond the Physician</title>
            <link>http://www.medworm.com/index.php?rid=4509252&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn104-article01.htm</link>
            <description>This article reviews the issue and includes tips for marketing to NPs and PAs. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4509252</comments>
            <pubDate>Wed, 23 Feb 2011 18:40:13 +0100</pubDate>
            <guid isPermaLink="false">4509252</guid>        </item>
        <item>
            <title>GSK's U.S. Sales Reps &quot;Europeanized&quot;</title>
            <link>http://www.medworm.com/index.php?rid=4486014&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FEUREP</link>
            <description>GSK's sales &quot;reps&quot; will no longer receive commissions &quot;based on their ability to push prescriptions. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4486014</comments>
            <pubDate>Thu, 17 Feb 2011 16:29:23 +0100</pubDate>
            <guid isPermaLink="false">4486014</guid>        </item>
        <item>
            <title>Good Promotion Practices Alliance</title>
            <link>http://www.medworm.com/index.php?rid=4486010&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn103-article01.htm</link>
            <description>Plenty of attention being paid to pharmaceutical marketing fraud and abuse cases in blogs and in the general media. But there hasn't been much attention paid to good compliance solutions or best practices. That's the mission of the Good Promotion Practices Alliance (GPP), which is co-sponsored by Reprints Desk and Prolifiq Software. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4486010</comments>
            <pubDate>Thu, 17 Feb 2011 16:29:09 +0100</pubDate>
            <guid isPermaLink="false">4486010</guid>        </item>
        <item>
            <title>The Socialisation of the Internet is Bogus</title>
            <link>http://www.medworm.com/index.php?rid=4486013&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2Fsmbogus</link>
            <description>How as an industry can we influence the exchange of ideas and information if we are not prepared to be where our audience and communities exist? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4486013</comments>
            <pubDate>Thu, 17 Feb 2011 16:28:54 +0100</pubDate>
            <guid isPermaLink="false">4486013</guid>        </item>
        <item>
            <title>FDA's Abrams Spends 4 Minutes Discussing Social Media Guidance at ePharma Summit!</title>
            <link>http://www.medworm.com/index.php?rid=4486012&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FDDMAC4min</link>
            <description>Tom Abrams, the Head of FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC), apparently believes Twitter and YouTube are passing fads. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4486012</comments>
            <pubDate>Thu, 17 Feb 2011 16:28:22 +0100</pubDate>
            <guid isPermaLink="false">4486012</guid>        </item>
        <item>
            <title>Breaking the 140-character Limit of Twitter Opens the Door to FDA-Compliant Branded Tweets</title>
            <link>http://www.medworm.com/index.php?rid=4486011&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FDECKly</link>
            <description>Deck.ly has enormous potential for pharmaceutical marketers who have been chaffing at the bit to post meaningful branded messages via Twitter but who have been stymied by lack of guidance from FDA regarding how to provide fair balance within the 140-character limit of Twitter. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4486011</comments>
            <pubDate>Thu, 17 Feb 2011 16:27:49 +0100</pubDate>
            <guid isPermaLink="false">4486011</guid>        </item>
        <item>
            <title>Elitist Pharmaceutical Marketing</title>
            <link>http://www.medworm.com/index.php?rid=4365778&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FfTeZm1</link>
            <description>Why do pharma marketers spend millions of dollars on celebrities like Phil Mickelson to promote products to an elite audience such as golfers when the money can better be spent reaching the poorer masses huddled around their TVs watching Dancing with the Stars? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4365778</comments>
            <pubDate>Wed, 19 Jan 2011 15:39:50 +0100</pubDate>
            <guid isPermaLink="false">4365778</guid>        </item>
        <item>
            <title>Deal with Lack of Regulations by Developing Best Practices</title>
            <link>http://www.medworm.com/index.php?rid=4365773&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_102_Upfront.pdf</link>
            <description>The pharma industry must continue to deal with a LACK of guidance from the FDA regarding social media communications. That's fine, because guidance or no guidance, best practices in social media communications is still evolving. A few pharma companies are ahead of the pack in that regard. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4365773</comments>
            <pubDate>Wed, 19 Jan 2011 15:39:22 +0100</pubDate>
            <guid isPermaLink="false">4365773</guid>        </item>
        <item>
            <title>Amgen Blows Its Marketing Budget on Phil Mickelson Campaign</title>
            <link>http://www.medworm.com/index.php?rid=4365777&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2FhM0gI3</link>
            <description>Whether or not Phil was on the pharma payroll when he revealed he was taking ENBREL to treat his psoriatic arthritis and also claimed &quot;I have no aches and pains. My back feels great. I feel stronger and more flexible than I've ever been&quot; is a moot point. However, payng for Phil may have blown Amgen's patient-support/marketing budget. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4365777</comments>
            <pubDate>Wed, 19 Jan 2011 15:38:05 +0100</pubDate>
            <guid isPermaLink="false">4365777</guid>        </item>
        <item>
            <title>FDA Says There are &quot;No simple solutions&quot; to Speed Up Its Regulatory Guidance Process</title>
            <link>http://www.medworm.com/index.php?rid=4365776&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fbit.ly%2Fiawrfb</link>
            <description>Timeliness of issuing FDA guidance was top of mind in 2010 for the many pharma marketers who waited for social media/internet draft guidance that the FDA hoped would be released before the end of 2010. FDA took note of several comments it received stating that the timeliness of its regulatory guidance process must be improved. In response, an FDA Transparency Task Force report says that &quot;there are no simple solutions to such problems.&quot; (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4365776</comments>
            <pubDate>Wed, 19 Jan 2011 15:34:53 +0100</pubDate>
            <guid isPermaLink="false">4365776</guid>        </item>
        <item>
            <title>Getting Market Research Right in India &amp; China</title>
            <link>http://www.medworm.com/index.php?rid=4365775&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn101-article02.htm</link>
            <description>This is the last in a series of three articles highlighting points made by Kantar Health executives in a recent webinar titled, &quot;Getting It Right in the Emerging Markets: Identifying the opportunities and avoiding the pitfalls in conducting market research in new geographies.&quot; (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4365775</comments>
            <pubDate>Wed, 19 Jan 2011 15:30:43 +0100</pubDate>
            <guid isPermaLink="false">4365775</guid>        </item>
        <item>
            <title>Strategies for Marketing Compliance</title>
            <link>http://www.medworm.com/index.php?rid=4365774&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn102-article01.htm</link>
            <description>This article offers a few thoughts from a physician's point. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4365774</comments>
            <pubDate>Wed, 19 Jan 2011 15:28:48 +0100</pubDate>
            <guid isPermaLink="false">4365774</guid>        </item>
        <item>
            <title>Welcome to the 2010 Pharma Marketing YearBook</title>
            <link>http://www.medworm.com/index.php?rid=4353667&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn101-upfront.htm</link>
            <description>Welcome to Volume 10, Issue No. 1 (Jan 12, 2011) of Pharma Marketing News. This issue of Pharma Marketing News is devoted to the Pharma Marketing Yearbook (PMY), which is a commemorative record of pharmaceutical marketing issues and highlights of the past year. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4353667</comments>
            <pubDate>Sun, 16 Jan 2011 17:31:25 +0100</pubDate>
            <guid isPermaLink="false">4353667</guid>        </item>
        <item>
            <title>Events I Witnessed, News You Made, &amp; People We Met</title>
            <link>http://www.medworm.com/index.php?rid=4340047&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn101-article01.htm</link>
            <description>The year 2010 was all about me. By 'me' I mean Pharmaguy, which is the Twitter handle and Facebook name of John Mack, Editor and Publisher of Pharma Marketing News. It's all about YOU too! This is where you can 'sign' the 2010 Pharma Marketing Yearbook and and document that you were part of it all. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4340047</comments>
            <pubDate>Thu, 13 Jan 2011 18:10:36 +0100</pubDate>
            <guid isPermaLink="false">4340047</guid>        </item>
        <item>
            <title>Pharma Companies Behaving Badly</title>
            <link>http://www.medworm.com/index.php?rid=4340050&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn101-article04.htm</link>
            <description>Every year without fail there are revelations about pharmaceutical companies behaving badly -- companies that have been charged with crimes such as making kickbacks to physicians, engaging in Medicare and Medicaid fraud, promoting products off label to physicians or companies that are called to testify before Congress about sub par manufacturing practices. 2010 seems to be unique in the number of companies behaving badly. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4340050</comments>
            <pubDate>Thu, 13 Jan 2011 17:55:15 +0100</pubDate>
            <guid isPermaLink="false">4340050</guid>        </item>
        <item>
            <title>Welcome to the 2010 Pharma Marketing YearBook&amp;trade;</title>
            <link>http://www.medworm.com/index.php?rid=4340046&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn101-upfront.htm</link>
            <description>Welcome to Volume 10, Issue No. 1 (Jan 12, 2011) of Pharma Marketing News. This issue of Pharma Marketing News is devoted to the Pharma Marketing Yearbook (PMY), which is a commemorative record of pharmaceutical marketing issues and highlights of the past year. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4340046</comments>
            <pubDate>Thu, 13 Jan 2011 17:54:47 +0100</pubDate>
            <guid isPermaLink="false">4340046</guid>        </item>
        <item>
            <title>Pharma Spending on Internet, DTC, and Docs</title>
            <link>http://www.medworm.com/index.php?rid=4340049&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn101-article03.htm</link>
            <description>How much money the pharmaceutical industry spends on Internet marketing, direct-to-consumer advertising, and physician detailing are always topics of interest and 2010 was no exception. 2010 was, however, a turning point in bringing more attention to payments made to physicians for speaking, consulting, and research. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4340049</comments>
            <pubDate>Thu, 13 Jan 2011 17:44:40 +0100</pubDate>
            <guid isPermaLink="false">4340049</guid>        </item>
        <item>
            <title>Pharma Social Media Trials &amp; Tribulations</title>
            <link>http://www.medworm.com/index.php?rid=4340048&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn101-article02.htm</link>
            <description>Social media occupied a good deal of our attention in 2010 and many of the pharma people Pharmaguy met and interacted with in 2010 are involved in social media campaigns in one way or another. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4340048</comments>
            <pubDate>Wed, 12 Jan 2011 14:30:28 +0100</pubDate>
            <guid isPermaLink="false">4340048</guid>        </item>
        <item>
            <title>Pharma's 2010 Christmas Wish List for Santa</title>
            <link>http://www.medworm.com/index.php?rid=4269446&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_910_UpFront.pdf</link>
            <description>Included on the list: FDA social media guidelines (Duh!), pharma-friendly biosimilar regulations, increased drug pipeline, and others that you can read about in this OpEd piece, which provides background on these issues, as well as useful data and links to resources. Santa may not be able to solve all these problems, but it's worth a shot! (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4269446</comments>
            <pubDate>Fri, 17 Dec 2010 12:18:40 +0100</pubDate>
            <guid isPermaLink="false">4269446</guid>        </item>
        <item>
            <title>New Media Privacy Issues &amp; Online Health Marketing</title>
            <link>http://www.medworm.com/index.php?rid=4269447&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn910-article01.htm</link>
            <description>This article is a summary of a Center for Digital Democracy complaint filed with the FTC and a review of the issues. The article also includes a compilation of more than two dozen 'innovative&quot; online marketing products/solutions mentioned in the complaint. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4269447</comments>
            <pubDate>Fri, 17 Dec 2010 12:11:24 +0100</pubDate>
            <guid isPermaLink="false">4269447</guid>        </item>
        <item>
            <title>Capturing &amp; Reporting HCP-Related Meeting Spending</title>
            <link>http://www.medworm.com/index.php?rid=4210594&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn99-article03.htm</link>
            <description>This article is a summary of a Webinar by StarCite, which defined what pharma marketers and meeting planners need to know when it comes to meetings-related HCP reporting. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4210594</comments>
            <pubDate>Tue, 30 Nov 2010 16:45:55 +0100</pubDate>
            <guid isPermaLink="false">4210594</guid>        </item>
        <item>
            <title>Getting Market Research Right in the Middle East</title>
            <link>http://www.medworm.com/index.php?rid=4173657&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn99-article02.htm</link>
            <description>If the Middle East was a single country, it would be the fifth largest market in the world in terms of GDP. The sales of pharmaceuticals in the Middle East surpasses 20 billion US dollars per year and is growing by 10 to 15% per year. This is the second in a series of three articles highlighting points made by Kantar Health executives in a recent webinar titled &quot;Getting It Right in the Emerging Markets: Identifying the opportunities and avoiding the pitfalls in conducting market research in new geographies.&quot; (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4173657</comments>
            <pubDate>Tue, 16 Nov 2010 20:31:58 +0100</pubDate>
            <guid isPermaLink="false">4173657</guid>        </item>
        <item>
            <title>Pharma Collaboration with Online Patient Opinion Leaders</title>
            <link>http://www.medworm.com/index.php?rid=4153750&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_99_UpFront.pdf</link>
            <description>It's time to determine the issues involving transparency and conflicts of interest that may arise if and when pharma companies pay individual &quot;Patient Opinion Leaders&quot; (POLs) to help manage their engagement with patients online. What best practices should govern pharma's collaboration with POLs? Should the industry develop guidelines for their interactions with POLs? This OpEd is a call for action and input from readers regarding these issues and questions. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4153750</comments>
            <pubDate>Wed, 10 Nov 2010 15:17:54 +0100</pubDate>
            <guid isPermaLink="false">4153750</guid>        </item>
        <item>
            <title>Physician-Generated Content on Social Media Sites</title>
            <link>http://www.medworm.com/index.php?rid=4153751&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn99-article01.htm</link>
            <description>This article highlights results of a survey of physician members of DocCheck, a leading European physician online social network and portal site. The survey assessed the type of networks used, the frequency of posting, motivation for posting, estimation of network usage, relevance of content posted and an evaluation of the importance of online physician-generated content in the future. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4153751</comments>
            <pubDate>Wed, 10 Nov 2010 14:56:45 +0100</pubDate>
            <guid isPermaLink="false">4153751</guid>        </item>
        <item>
            <title>Getting Market Research Right in Emerging Markets</title>
            <link>http://www.medworm.com/index.php?rid=4153752&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn98-article03.htm</link>
            <description>This is the first in a series of articles summarizing highlights from a recent webinar focused on getting market research right in emerging markets. It features experts from Kantar Health, a global consultancy and marketing insights organization that was formed in 2009 by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4153752</comments>
            <pubDate>Thu, 28 Oct 2010 13:55:10 +0100</pubDate>
            <guid isPermaLink="false">4153752</guid>        </item>
        <item>
            <title>Digital Pharma Is Alive and Well in Europe!</title>
            <link>http://www.medworm.com/index.php?rid=4070501&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn98-article02.htm</link>
            <description>These highlights from the 2010 DigiPharm EU conference summarizes presentations made by marketing specialists from Lundbeck, Janssen, GSK, Schering Plough, Boehringer Ingelheim, Pfizer, Genzyme and Merck Serono. It's a summary of the best current practices and a glimpse at how EU pharma companies are driving digital marketing and communications forward. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4070501</comments>
            <pubDate>Fri, 15 Oct 2010 17:30:25 +0100</pubDate>
            <guid isPermaLink="false">4070501</guid>        </item>
        <item>
            <title>Integration of Custom Media into the Marketing Mix</title>
            <link>http://www.medworm.com/index.php?rid=4063401&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn98-article01.htm</link>
            <description>This article summarizes a discussion with Abraham Ogden, the Director of Book Publications for the American Diabetes Association, about integrating ADA's custom publications into the pharma marketing mix. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4063401</comments>
            <pubDate>Wed, 13 Oct 2010 10:38:25 +0100</pubDate>
            <guid isPermaLink="false">4063401</guid>        </item>
        <item>
            <title>Social Media and the Limitations of Disease Awareness Campaigns</title>
            <link>http://www.medworm.com/index.php?rid=4063402&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_98_UpFront.pdf</link>
            <description>Disease awareness (DA) campaigns have limitations that even well-executed social media campaigns cannot overcome. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4063402</comments>
            <pubDate>Tue, 12 Oct 2010 17:30:46 +0100</pubDate>
            <guid isPermaLink="false">4063402</guid>        </item>
        <item>
            <title>Closed-Loop Patient Education</title>
            <link>http://www.medworm.com/index.php?rid=3996400&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn97-article03.htm</link>
            <description>MedTera recently partnered with HealthPrize Technologies, a web-based software company that motivates people to fill and stay on prescription medications, to bring together MedTera's online and offline educational resources and HealthPrize's online, interactive platform to educate people about their chronic diseases and incentivize them for taking their medications as prescribed. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3996400</comments>
            <pubDate>Thu, 23 Sep 2010 13:09:43 +0100</pubDate>
            <guid isPermaLink="false">3996400</guid>        </item>
        <item>
            <title>Eyes on the Adherence Prize</title>
            <link>http://www.medworm.com/index.php?rid=3996401&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn97-article02.htm</link>
            <description>This article provides details about the HealthPrize's innovative, compelling approach to solving one of pharma's most perplexing puzzle: how to improve medication adherence. Included is a summary of a Pharma Marketing Talk podcast interview of Tom Kottler, CEO, and Katrina S. Firlik, M.D., Chief Medical Officer, HealthPrize. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3996401</comments>
            <pubDate>Thu, 23 Sep 2010 13:08:51 +0100</pubDate>
            <guid isPermaLink="false">3996401</guid>        </item>
        <item>
            <title>Solving the Adherence Problem in Economic Hard Times</title>
            <link>http://www.medworm.com/index.php?rid=3923189&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_97_UpFront.pdf</link>
            <description>Medication non-adherence -- ie, patients not taking their medications as prescribed by their doctors -- is one of the most significant problems in healthcare. It is an even bigger problem during economic hard times as more people cut back their medications to save money. There are many facets to this problem, which cannot simply be solved by lowering drug costs. 

This month's Pharma Marketing News includes several articles that feature innovative solutions to the adherence problem. In preparation for these articles, several experts will be guests on the Pharma Marketing BlogTalkRadio Show during the month of September. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3923189</comments>
            <pubDate>Wed, 01 Sep 2010 16:57:04 +0100</pubDate>
            <guid isPermaLink="false">3923189</guid>        </item>
        <item>
            <title>Pharma, Physicians, and Sermo</title>
            <link>http://www.medworm.com/index.php?rid=3923190&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn97-article01.htm</link>
            <description>This article provides an overview of Sermo's new Client Center and summarizes a Pharma Marketing Talk podcast interview of with Daniel Palestrant, Sermo's Founder and Chief Executive Officer. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3923190</comments>
            <pubDate>Wed, 01 Sep 2010 16:55:56 +0100</pubDate>
            <guid isPermaLink="false">3923190</guid>        </item>
        <item>
            <title>Just-in-Time Publishing</title>
            <link>http://www.medworm.com/index.php?rid=3825675&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_96_UpFront.pdf</link>
            <description>Beginning with this issue a new publication plan -- the Just-in-Time Publishing plan -- is being implemented. This new publication schedule will benefit readers with more timely release of valuable information. It will benefit advertisers too. Read this OpEd piece to find out the details. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3825675</comments>
            <pubDate>Thu, 05 Aug 2010 13:22:46 +0100</pubDate>
            <guid isPermaLink="false">3825675</guid>        </item>
        <item>
            <title>The Pharmaguy Next Door</title>
            <link>http://www.medworm.com/index.php?rid=3825674&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn96-article03.htm</link>
            <description>John Mack, a.k.a. pharmaguy on Twitter, answers questions about his background and provides his opinions on how pharmaceutical companies will use social media in the future. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3825674</comments>
            <pubDate>Thu, 05 Aug 2010 13:22:46 +0100</pubDate>
            <guid isPermaLink="false">3825674</guid>        </item>
        <item>
            <title>Social Media Leaders Wanted</title>
            <link>http://www.medworm.com/index.php?rid=3800914&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn96-article02.htm</link>
            <description>This article reviews the results of Pharma Marketing News' What's Your Social Media Implementation Plan? survey and announces the details of the Pharmaguy Social Media Pioneer Award. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3800914</comments>
            <pubDate>Thu, 29 Jul 2010 16:34:21 +0100</pubDate>
            <guid isPermaLink="false">3800914</guid>        </item>
        <item>
            <title>The iPad as a Pharma Marketing Platform</title>
            <link>http://www.medworm.com/index.php?rid=3797087&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn96-article01.htm</link>
            <description>This article summarizes how the iPad is currently being used by the pharmaceutical industry, how it is being adopted by physicians, and what the roadblocks are to using it for eDetailing. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3797087</comments>
            <pubDate>Wed, 28 Jul 2010 14:51:40 +0100</pubDate>
            <guid isPermaLink="false">3797087</guid>        </item>
        <item>
            <title>Public Relations Communications in the Fast-paced World of Twitter</title>
            <link>http://www.medworm.com/index.php?rid=3597789&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_95_UpFront.pdf</link>
            <description>When it comes to crisis communications in the faced-paced digital world of blogging and Twitter, pharmaceutical companies have no roadmap to guide them. The J&amp;J/McNeil recall fiasco may be a case study on &quot;how-not-to&quot; manage crisis communications in the faced-paced digital world of blogging and Twitter. Pharma can learn from this case how, crisis or otherwise, one deals with the breakneck pace and two-way, consumer-driven nature of digital communications. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3597789</comments>
            <pubDate>Wed, 26 May 2010 10:17:02 +0100</pubDate>
            <guid isPermaLink="false">3597789</guid>        </item>
        <item>
            <title>Data Mining in the Deep, Dark Social Networks of Patients</title>
            <link>http://www.medworm.com/index.php?rid=3597792&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn95-article03.htm</link>
            <description>If pharma marketers wish to tap into closed online patient communities that are rich sources of information, they need to pay careful attention to the rules lest they suffer the consequences to their reputations. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3597792</comments>
            <pubDate>Wed, 26 May 2010 10:16:34 +0100</pubDate>
            <guid isPermaLink="false">3597792</guid>        </item>
        <item>
            <title>ePrints NRx for Physician Detailing</title>
            <link>http://www.medworm.com/index.php?rid=3597791&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn95-article02.htm</link>
            <description>This article describes and summarizes the features and benefits of the Reprints Desk's ePrints NRx solution -- a new scientific article collection service that simplifies the re-use of PDFs by medical marketers, brand managers, and sales professionals. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3597791</comments>
            <pubDate>Wed, 26 May 2010 10:16:07 +0100</pubDate>
            <guid isPermaLink="false">3597791</guid>        </item>
        <item>
            <title>The Changing Pharma Commercial Model in 2010 and Beyond</title>
            <link>http://www.medworm.com/index.php?rid=3597790&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn95-article01.htm</link>
            <description>This article features a summary of the much anticipated NEW Kantar Health TRI*M annual survey results with physicians across the U.S. and Europe on their service expectations -- plus how they rate 16 Pharma companies on reps, relationships and services. The survey looked not only at PCPs/GPs but also -- for the first time -- at what oncologists expect from the industry. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3597790</comments>
            <pubDate>Wed, 26 May 2010 10:15:29 +0100</pubDate>
            <guid isPermaLink="false">3597790</guid>        </item>
        <item>
            <title>Use of Social Media for Health Purposes in the EU</title>
            <link>http://www.medworm.com/index.php?rid=3521627&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn94-article04.htm</link>
            <description>This article is a summary of the EPG Health Media (part of the IMR International Group) market research report &quot;Social Media and Healthcare,&quot; which examines how European doctors, patients/consumers and pharma engage (and seek to engage) with each other. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3521627</comments>
            <pubDate>Fri, 30 Apr 2010 14:54:06 +0100</pubDate>
            <guid isPermaLink="false">3521627</guid>        </item>
        <item>
            <title>What's Your Social Media Implementation Plan?</title>
            <link>http://www.medworm.com/index.php?rid=3521623&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_94_UpFront.pdf</link>
            <description>Sanofi-Aventis's recent Facebook experience with comments posted to its wall provoked a lot of new thinking about how to manage pharma social networks rather than how the FDA should regulate pharma use of social media. We've just passed a new milestone and entered a pharma social media implementation phase. Are you ready? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3521623</comments>
            <pubDate>Fri, 30 Apr 2010 14:54:06 +0100</pubDate>
            <guid isPermaLink="false">3521623</guid>        </item>
        <item>
            <title>Moderation Best Practices for Pharma Social Networks</title>
            <link>http://www.medworm.com/index.php?rid=3521626&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn94-article03.htm</link>
            <description>This article presents a summary of results from a recent survey of readers and other experts regarding pharma social media moderation best practices. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3521626</comments>
            <pubDate>Fri, 30 Apr 2010 14:53:50 +0100</pubDate>
            <guid isPermaLink="false">3521626</guid>        </item>
        <item>
            <title>How to Manage the Online Conversation</title>
            <link>http://www.medworm.com/index.php?rid=3521625&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn94-article02.htm</link>
            <description>This article presents a summary of results from a recent survey of readers and other experts regarding pharma social media moderation best practices. This article presents a summary of a conversation with Jenna Woodul, LiveWorld's EVP and Chief Community Officer, about how pharma companies can manage their social media interactions using technology and credentialed participants. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3521625</comments>
            <pubDate>Fri, 30 Apr 2010 14:52:21 +0100</pubDate>
            <guid isPermaLink="false">3521625</guid>        </item>
        <item>
            <title>Real Patient Testimonials</title>
            <link>http://www.medworm.com/index.php?rid=3521624&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn94-article01.htm</link>
            <description>This article discusses the potential pitfalls, regulatory issues, and best practices regarding the use of real patient testimonials based on comments collected from a recent survey of readers and other experts. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3521624</comments>
            <pubDate>Fri, 30 Apr 2010 14:51:42 +0100</pubDate>
            <guid isPermaLink="false">3521624</guid>        </item>
        <item>
            <title>Solving the Social Media Adverse Event Reporting Problem</title>
            <link>http://www.medworm.com/index.php?rid=3427046&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn93-article04.htm</link>
            <description>Many presenters at FDA's November 2009 public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools addressed this problem and offered solutions. Comments submitted to the FDA after the meeting offer more details, which are reviewed in this article. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3427046</comments>
            <pubDate>Wed, 31 Mar 2010 17:57:19 +0100</pubDate>
            <guid isPermaLink="false">3427046</guid>        </item>
        <item>
            <title>FDA Can Relax. I Did All the Work for Them!</title>
            <link>http://www.medworm.com/index.php?rid=3427041&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_93_UpFront.pdf</link>
            <description>The March 2010 issue of Pharma Marketing News does practically all the work for the FDA in summarizing comments submitted to FDA's docket regarding &quot;Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools.&quot; (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3427041</comments>
            <pubDate>Wed, 31 Mar 2010 17:57:19 +0100</pubDate>
            <guid isPermaLink="false">3427041</guid>        </item>
        <item>
            <title>Accountability for Pharma Content on Social Media Sites</title>
            <link>http://www.medworm.com/index.php?rid=3427045&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn93-article03.htm</link>
            <description>A substantial portion of drug industry comments submitted to the FDA was devoted to how pharmaceutical companies should be held accountable for a communication about its product(s) and how much control they exert over activities on the Internet and social media. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3427045</comments>
            <pubDate>Wed, 31 Mar 2010 17:56:46 +0100</pubDate>
            <guid isPermaLink="false">3427045</guid>        </item>
        <item>
            <title>Overcoming Space Limitations in Social Media</title>
            <link>http://www.medworm.com/index.php?rid=3427044&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn93-article02.htm</link>
            <description>This article presents a summary of comments to FDA from the drug industry addressing regulatory concerns when using social media tools associated with space limitations or tools that allow for real-time communications to present product information. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3427044</comments>
            <pubDate>Wed, 31 Mar 2010 17:56:06 +0100</pubDate>
            <guid isPermaLink="false">3427044</guid>        </item>
        <item>
            <title>Industry and Consumer Advocates Square Off Regarding Social Media</title>
            <link>http://www.medworm.com/index.php?rid=3427043&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn93-article01.htm</link>
            <description>This article presents an overview of the types of organizations that submitted comments versus those that made presentations at the November 2009 public hearing. It also includes general comments from the pharma industry regarding the process by which the FDA should regulate the Internet and social media. Also presented in this article are the comments submitted by consumer advocates and individuals who generally supported more strict regulation across the board. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3427043</comments>
            <pubDate>Wed, 31 Mar 2010 17:55:31 +0100</pubDate>
            <guid isPermaLink="false">3427043</guid>        </item>
        <item>
            <title>Use of Behavioral Targeting by Pharma Marketers</title>
            <link>http://www.medworm.com/index.php?rid=3304816&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn92-article04.htm</link>
            <description>This article summarizes the results of a survey designed to answer the questions: Should the pharmaceutical industry adopt similar self-regulatory principles that were established by media and marketing trade associations to protect consumer privacy when employing behavioral targeting, Should pharma marketers use behavioral targeting at all?, If they do use it, when is it appropriate? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3304816</comments>
            <pubDate>Thu, 25 Feb 2010 14:15:57 +0100</pubDate>
            <guid isPermaLink="false">3304816</guid>        </item>
        <item>
            <title>Waiting for Goduidance</title>
            <link>http://www.medworm.com/index.php?rid=3304812&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_92_UpFront.pdf</link>
            <description>It seems like every pharmaceutical marketer is waiting for guidance from the FDA before they do more online marketing and especially more social media marketing. It's like Waiting for Godot -- guidance may never come. What then? Or it could come. Then what? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3304812</comments>
            <pubDate>Thu, 25 Feb 2010 14:15:57 +0100</pubDate>
            <guid isPermaLink="false">3304812</guid>        </item>
        <item>
            <title>Pharma's Social Media Working Group</title>
            <link>http://www.medworm.com/index.php?rid=3304815&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn92-article03.htm</link>
            <description>This article reviews the Who, What, and Why of Pharma's Social Media Working Group (SMWG) based on a conversation with Mark Gaydos, Senior Director, U.S. Regulatory Affairs Marketed Products at sanofi-aventis, and Cynthia Phillips, Sr Dir Labeling and Promotional Compliance at Millennium Pharmaceuticals. Also covered is an analysis of comments the SMWG submitted to the FDA on how pharmaceutical companies should handle off-label and adverse event posts made on social media sites owned or sponsored by them. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3304815</comments>
            <pubDate>Thu, 25 Feb 2010 14:15:48 +0100</pubDate>
            <guid isPermaLink="false">3304815</guid>        </item>
        <item>
            <title>Building the &quot;New&quot; Pharma Physician Marketing Model</title>
            <link>http://www.medworm.com/index.php?rid=3304814&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn92-article02.htm</link>
            <description>This article reviews MedTera's HC Professional &quot;Life Long Learning&quot; Platform -- branded integrated physician marketing solutions -- and presents a summary of research on how brand teams see the mix of marketing tactics changing over the next several years. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3304814</comments>
            <pubDate>Thu, 25 Feb 2010 14:15:04 +0100</pubDate>
            <guid isPermaLink="false">3304814</guid>        </item>
        <item>
            <title>Use of Twitter for Patient Support</title>
            <link>http://www.medworm.com/index.php?rid=3304813&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn92-article01.htm</link>
            <description>This article summarizes a survey that asked respondents to evaluate several ways in which Twitter could be used to improve patient support. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3304813</comments>
            <pubDate>Thu, 25 Feb 2010 14:14:14 +0100</pubDate>
            <guid isPermaLink="false">3304813</guid>        </item>
        <item>
            <title>Healthcare Communications vs. Pharma Marketing</title>
            <link>http://www.medworm.com/index.php?rid=3210490&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_91_UpFront.pdf</link>
            <description>Whenever someone refers to a pharmaceutical company as a &quot;healthcare company&quot; the hairs on the back of my neck (where I still have some hair) rise up. Are pharmaceutical companies healthcare companies? Should we replace &quot;pharmaceutical marketing&quot; with &quot;healthcare communications?&quot; (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3210490</comments>
            <pubDate>Wed, 27 Jan 2010 14:30:43 +0100</pubDate>
            <guid isPermaLink="false">3210490</guid>        </item>
        <item>
            <title>Pharma Begins to Reveal Payments to Physicians</title>
            <link>http://www.medworm.com/index.php?rid=3210493&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn91-article03.htm</link>
            <description>This article reviews the physician payment lists published by Lilly, Merck, and GSK. The analysis gives us more insight into the fees paid by various companies, how the money was distributed by state and region in the US, and what types of activities (eg, speaker fees vs. consulting fees) physicians were paid to perform. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3210493</comments>
            <pubDate>Wed, 27 Jan 2010 14:30:37 +0100</pubDate>
            <guid isPermaLink="false">3210493</guid>        </item>
        <item>
            <title>Corporate Reputation in the New Media World</title>
            <link>http://www.medworm.com/index.php?rid=3210492&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn91-article02.htm</link>
            <description>This article summarizes the presentations made at that webinar. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3210492</comments>
            <pubDate>Wed, 27 Jan 2010 14:29:47 +0100</pubDate>
            <guid isPermaLink="false">3210492</guid>        </item>
        <item>
            <title>Predicting the Future of the Drug Industry</title>
            <link>http://www.medworm.com/index.php?rid=3210491&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn91-article01.htm</link>
            <description>This article reviews the results of the 'Predicting the Future of the Drug Industry: 2010 &amp; Beyond!' survey and provides background on future trends. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3210491</comments>
            <pubDate>Wed, 27 Jan 2010 14:28:58 +0100</pubDate>
            <guid isPermaLink="false">3210491</guid>        </item>
        <item>
            <title>Pharma's Image Conundrum</title>
            <link>http://www.medworm.com/index.php?rid=3094722&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn810-article04.htm</link>
            <description>Building Brand Loyalty and Consumer Confidence

In this guest article, Carla Stratfold, CEO at OnRequest Images, presents several key learnings and best practices that pharmas can follow when building brand and consumer loyalty (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094722</comments>
            <pubDate>Wed, 16 Dec 2009 20:56:19 +0100</pubDate>
            <guid isPermaLink="false">3094722</guid>        </item>
        <item>
            <title>What's Next from FDA?</title>
            <link>http://www.medworm.com/index.php?rid=3094718&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_810_UpFront.pdf</link>
            <description>Now that the FDA public hearing about regulating drug and medical device promotion on the Internet has come and gone, everyone who has a stake in the issues discussed at that hearing is wondering what the next steps are. Practically everyone believes the FDA will issue some form of guidance for the industry. Here's a list of important questions for FDA from our readers. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094718</comments>
            <pubDate>Wed, 16 Dec 2009 20:56:19 +0100</pubDate>
            <guid isPermaLink="false">3094718</guid>        </item>
        <item>
            <title>A Few Things I Learned at FDA's Social Media Hearing</title>
            <link>http://www.medworm.com/index.php?rid=3094721&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn810-article03.htm</link>
            <description>This article presents key takeaways from the FDA hearing, a synopsis of the presentations made by John Mack, Publisher, Pharma Marketing News, at the hearing, a review of Ignite Health's study regarding effectiveness of sponsored links, and the next steps in the process of issuing guidance. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094721</comments>
            <pubDate>Wed, 16 Dec 2009 20:56:14 +0100</pubDate>
            <guid isPermaLink="false">3094721</guid>        </item>
        <item>
            <title>Search Advertising Options for Pharma</title>
            <link>http://www.medworm.com/index.php?rid=3094720&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn810-article02.htm</link>
            <description>What to Do While Waiting for Those Guidelines
In this article, Julie Batten, eMarketing Manager at Klick Pharma discusses pharma's options for search marketing in this period between the FDA public hearing and when the much anticipated draft and final guidance on the issue is published. (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094720</comments>
            <pubDate>Wed, 16 Dec 2009 20:55:27 +0100</pubDate>
            <guid isPermaLink="false">3094720</guid>        </item>
        <item>
            <title>Consequences of DTCA</title>
            <link>http://www.medworm.com/index.php?rid=3094719&amp;cid=s_38166_34_f&amp;fid=38166&amp;url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn810-article01.htm</link>
            <description>This article focuses on a new study that suggests drug price increases are engineered to cover the costs of Direct-to-Consumer Advertising (DTCA). Drug price trend data from AARP, AHRQ, and prescription drug consumer price index (CPI) are presented. Also, what's the link between DTCA and competition? (Source: Pharma Marketing News)</description>
            <author>Pharma Marketing News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094719</comments>
            <pubDate>Wed, 16 Dec 2009 20:54:18 +0100</pubDate>
            <guid isPermaLink="false">3094719</guid>        </item>
    </channel>
</rss>

